Back to News
Market Impact: 0.35
Eurobio Scientific: EB Development, actionnaire majoritaire d’Eurobio Scientific, annonce son intention de déposer une offre publique de retrait suivie d'un retrait obligatoire, au prix de 25,30 € par action
Source: GlobeNewswire
M&A & RestructuringCompany Fundamentals
EB Development, Eurobio Scientific’s majority shareholder, intends to launch a public buyout offer followed by a compulsory squeeze-out at €25.30 per share. The transaction would take Eurobio Scientific private, providing minority shareholders with a defined cash exit price.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
ALERS0.65
More News
- Why Wendy’s is losing the burger wars—and is now a takeover target for Nelson Peltz
- Companies promised AI gains— here's how the payoff showed up in earnings
- FBI blames North Korea for record $6.3bn crypto heist
- Binance to resume crypto withdrawals in phases after record $6 billion hack
- AWS grows 39% and Amazon will spend even more on AI in 2027
- SpaceX loses bid to toss NAACP lawsuit over Memphis data center air pollution